Ketamine, a glutamate N-methyl-d-aspartate receptor antagonist, has shown rapid antidepressant effects in treatment-resistant depression. We conducted a systematic review of studies evaluating the efficacy of intravenous ketamine augmentation in treatment-resistant depression patients with bipolar disorder.

中文翻译：

---

对静脉内消旋氯胺酮治疗双相抑郁症疗效的系统评价。

氯胺酮是一种谷氨酸 N-甲基-d-天冬氨酸受体拮抗剂，已在难治性抑郁症中显示出快速的抗抑郁作用。我们对评估静脉注射氯胺酮对患有双相情感障碍的难治性抑郁症患者的疗效的研究进行了系统评价。